Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 10:07 ET | Source: PridCor Therapeutics, LLC

PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program

PridCor Therapeutics advances its SHIELD Long COVID study with a peer-reviewed publication and FDA confirmation of IND exemption.
September 04, 2025 10:32 ET | Source: PridCor Therapeutics, LLC

PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen

PridCor reports Long COVID case series: combo of valacyclovir, celecoxib & Paxlovid® shows significant, lasting symptom improvement.